London & Capital Asset Management Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 1767559 London, X0

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$298,541

+$18,687 QoQ

Shares Held

2,363

+17.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,649

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

London & Capital Asset Management Ltd holds $7,884,378 across 5 Drug Manufacturers - General names. GILD ranks #5 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,513	$2,416,016
2	LLY	ELI LILLY & Co	1,987	$2,383,267
3	MRK	Merck & Co., Inc.	10,993	$1,412,600
4	ABBV	AbbVie Inc.	5,460	$1,373,954
5	GILD	Gilead Sciences, Inc. This page	2,363	$298,541

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$298,541	2,363	+17.7%	Shares	Sole	2026-08-12
2026-03-31	$279,854	2,008	-32.6%	Shares	Sole	2026-05-15
2025-12-31	$365,642	2,979	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.